Hematoxylin, an Alternative Substrate of Tyrosinase

Abstract

Mushroom tyrosinase from Agaricus bisporus (abTYR) is often used during the development of tyrosinase inhibitors for medicinal and cosmetic purposes. In the search for novel tyrosinase inhibitors, this study identified hematoxylin as an alternative substrate for abTYR. The interaction of hematoxylin with abTYR was investigated through spectrophotometric and chromatographic analyses. The results showed that hematoxylin acted as an abTYR substrate and exhibited Michaelis–Menten kinetic behaviour at concentrations below 1.25 mM. The substrate properties of hematoxylin were similar to the natural tyrosinase substrate, L-3,4-dihydroxyphenylalanine (L-DOPA), with regards to K_m, while V_max was eightfold lower. The main oxidation product formed during the reaction of abTYR with hematoxylin was identified as hematein. This is the first report of the interaction of hematoxylin with abTYR.

Keywords

Agaricus bisporus - tyrosinase - hematoxylin - tyrosinase inhibitor

Publikationsverlauf

Eingereicht: 28. Mai 2024

Angenommen nach Revision: 30. Juli 2024

Artikel online veröffentlicht:
19. August 2024

• References

• 1 Hearing VJ, Jiménez M. Mammalian tyrosinase – The critical regulatory control point in melanocyte pigmentation. Int J Biochem 1987; 19: 1141-1147
• 2 Slominski A, Tobin DJ, Shibahara S, Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 2004; 84: 1155-1228
• 3 Sánchez-Ferrer A, Rodríguez-López JN, García-Cánovas F, García-Carmona F. Tyrosinase: a comprehensive review of its mechanism. Biochim Biophys Acta 1995; 1247: 1-11
• 4 Zolghadri S, Bahrami A, Hassan Khan MT, Munoz-Munoz J, Garcia-Molina F, Garcia-Canovas F, Saboury AA. A comprehensive review on tyrosinase inhibitors. J Enzyme Inhib Med Chem 2019; 34: 279-309
• 5 Pillaiyar T, Manickam M, Namasivayam V. Skin whitening agents: Medicinal chemistry perspective of tyrosinase inhibitors. J Enzyme Inhib Med Chem 2017; 32: 403-425
• 6 Roulier B, Pérès B, Haudecoeur R. Advances in the design of genuine human tyrosinase inhibitors for targeting melanogenesis and related pigmentations. J Med Chem 2020; 63: 13428-13443
• 7 Carradori S, Melfi F, Rešetar J, Şimşek R. Tyrosinase Enzyme and its Inhibitors: An Update of the Literature. In: Supuran CT, Donald WA. editor Metalloenzymes. Cambridge: Academic Press; 2024: 533-546
• 8 Mann T, Gerwat W, Batzer J, Eggers K, Scherner C, Wenck H, Stäb F, Hearing VJ, Röhm KH, Kolbe L. Inhibition of human tyrosinase requires molecular motifs distinctively different from mushroom tyrosinase. J Invest Dermatol 2018; 138: 1601-1608
• 9 Germanas JP, Wang S, Miner A, Hao W, Ready JM. Discovery of small-molecule inhibitors of tyrosinase. Bioorg Med Chem Lett 2007; 17: 6871-6875
• 10 Ortiz-Ruiz CV, Garcia-Molina Mdel M, Serrano JT, Tomas-Martinez V, Garcia-Canovas F. Discrimination between alternative substrates and inhibitors of tyrosinase. J Agric Food Chem 2015; 63: 2162-2171
• 11 Asthana S, Zucca P, Vargiu AV, Sanjust E, Ruggerone P, Rescigno A. Structure-activity relationship study of hydroxycoumarins and mushroom tyrosinase. J Agric Food Chem 2015; 63: 7236-7244
• 12 Marshall PN, Horobin RW. The oxidation products of hematoxylin and their role in biological staining. Histochem J 1972; 4: 493-503
• 13 Sokolova R, Degano I, Hromadová M, Bulíčková J, Gál M, Valášek M. Oxidation pathways of natural dye hematoxylin in aqueous solution. Collect Czechoslov Chem Commun 2010; 75: 1097-1114